Financhill
Sell
28

ALDX Quote, Financials, Valuation and Earnings

Last price:
$2.04
Seasonality move :
20.32%
Day range:
$2.08 - $2.26
52-week range:
$1.14 - $7.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.75x
Volume:
1.3M
Avg. volume:
2.9M
1-year change:
-43.78%
Market cap:
$124.2M
Revenue:
--
EPS (TTM):
-$0.94

ALDX Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for Aldeyra Therapeutics shares anticipate an average target of $8.29, ranging from a low estimate of $6.00 to a high estimate of $11.00. This average target implies a growth of 298.35% compared to the current stock price of $2.08.

Consensus Price Target

$8.29

Highest Price Target

$11.00

Lowest Price Target

$6.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 5 5

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

ALDX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 23.48% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.24% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 1.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock